Protamine-heparin membrane for cell microencapsulation.
Tatarkiewicz
K
K
Institute of Biocybernetics and Biomedical Engineering, Warsaw, Poland.
Sitarek
E
E
Fiedor
P
P
Sabat
M
M
Orlowski
T
T
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002214:Capsules; D002470:Cell Survival; D017690:Cell Transplantation / Q000379:methods*; D002478:Cells, Cultured; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000628:therapy*; D005947:Glucose / Q000494:pharmacology; D006084:Graft Rejection; D006493:Heparin; D007515:Islets of Langerhans / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D011094:Polyethyleneimine; D011479:Protamines; D051381:Rats; D017208:Rats, Wistar; D014183:Transplantation, Heterologous / Q000379:methods* / Q000502:physiology
D001786:Blood Glucose; D002214:Capsules; D011479:Protamines; C087063:protamine-heparin membrane; D011094:Polyethyleneimine; D006493:Heparin; D005947:Glucose